Skip to content

Stylized cells, blue

Category: Cell & Gene Therapy


Unlocking the Curative Power of Gene Therapies for All Patients

Recap from the November 2024 Bridging the Gap webinar The incredible potential of gene therapies like CAR-T and CRISPR to cure genetic diseases and cancers marks a new era in medicine, yet most patients still lack access to these life-saving treatments. For many, the promise of gene therapy remains out of reach due to barriers […]

Celebrating One Year of Bridging the Gap: A Transformative Webinar Series for the Cell and Gene Therapy Community

In November 2024, Azenta Life Sciences celebrated the one-year anniversary of its “Bridging the Gap” webinar series, an insightful resource in cell and gene therapy (CGT) education, co-sponsored by the Emily Whitehead Foundation. Over the past year, this series has become a resource for industry experts and CGT professionals, offering critical insights and fostering impactful […]

The Future of Cell and Gene Therapy: Breaking Barriers to Access and Innovation

Recap from the October 2024 Bridging the Gap webinar In the rapidly advancing world of cell and gene therapy, we are witnessing groundbreaking innovations that have the potential to cure once-incurable diseases like cancer and sickle cell. Yet, as these transformative therapies emerge, a troubling reality persists: access to these life-saving treatments remains limited. Despite […]

Addressing Equity of Access to Advanced Therapies

Recap from the September 2024 Bridging the Gap webinar Access to life-saving cell and gene therapies is one of the most critical challenges facing healthcare today. While these therapies offer remarkable hope for patients battling life-threatening conditions like cancer and rare genetic diseases, the reality is that only a fraction of eligible patients are actually […]

Breaking Bottlenecks: Enhancing Autologous Cell Therapy Manufacturing

Insights from the August 2024 Bridging the Gap Webinar In the evolving landscape of cell and gene therapy, the manufacturing process is a crucial factor in ensuring that innovative treatments, such as CAR T-cell therapies, reach patients effectively. Autologous cell therapies, which involve modifying a patient’s own cells, present unique challenges that require precise coordination […]

Six Steps for a Successful Transition to Automated Cryogenic Storage

Imagine a scenario where a prominent life sciences company safeguards 573,000 biological samples collected two decades ago during a groundbreaking study. Today, these samples rest in a tucked-away basement of a modest laboratory, nestled among numerous cryogenic freezers within a section of the building inaccessible to anyone involved in the original research. The samples intermingle […]

Attacking Solid Tumors: TIL Revolution and Next Generation Advanced Therapies

Highlights from our July 2024 Bridging the Gap webinar Imagine harnessing your body’s own immune cells to fight and destroy cancer—a reality that Tumor-Infiltrating Lymphocytes (TIL) therapy is making possible. TIL therapy was the key topic of our July “Bridging the Gap” webinar with guest speaker Raj Puri, M.D., Ph.D. Dr. Puri, an Executive Vice […]

Shaping Tomorrow’s Standards of Care: Improving Patient Access to Advanced Therapies

Summary from Bridging the Gap Webinar Series May 2024 Welcome to another installment of the Bridging the Gap webinar series, your go-to place for the latest in cell and gene therapy. Presented by Azenta Life Sciences and the Emily Whitehead Foundation, this series is all about connecting the dots between groundbreaking science and real-world patient care. […]

Bridging the Gap: Enhancing Global Access to Advanced Therapies

Highlights from the June 2024 Bridging the Gap Webinar What if you could transform the life of a child with leukemia by simply modifying their own cells? This is the promise of CAR T-cell therapy, a groundbreaking treatment that has already revolutionized cancer care. Yet, as Siddhartha Mukherjee, M.D., Ph.D. passionately discussed in our latest Bridging […]

Addressing Challenges in Cryopreservation to Advance Cell and Gene Therapies

The field of cell and gene therapy (CGT) is experiencing an exciting transformation, marked by the recent FDA approval for the first CRISPR-based sickle cell treatment. As the CGT landscape rapidly expands, it’s important for stakeholders to address the challenges of scalability head-on. Cryopreservation emerges as a critical yet understated element in the scalability equation, essential for […]